These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 21791443)
1. Pharmacokinetics of oral voriconazole in patients with cystic fibrosis. Clifton IJ; Whitaker P; Metcalfe R; Phillip M; Shaw N; Conway SP; Peckham DG J Antimicrob Chemother; 2011 Oct; 66(10):2438-40. PubMed ID: 21791443 [No Abstract] [Full Text] [Related]
2. An alternative approach to determine oral bioavailability of drugs that follow Michaelis-Menten elimination: a case study with voriconazole. Verlindo de Araujo B; Farias da Silva C; Costa TD Pharmacology; 2010; 86(3):163-7. PubMed ID: 20714206 [TBL] [Abstract][Full Text] [Related]
3. Voriconazole pharmacokinetics and photosensitivity in children with cystic fibrosis. Markantonis SL; Katelari A; Pappa E; Doudounakis S J Cyst Fibros; 2012 May; 11(3):246-52. PubMed ID: 22284963 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of voriconazole after single dose intravenous and oral administration to alpacas. Chan HM; Duran SH; Walz PH; Ravis WR J Vet Pharmacol Ther; 2009 Jun; 32(3):235-40. PubMed ID: 19646087 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of voriconazole after oral and intravenous administration to horses. Davis JL; Salmon JH; Papich MG Am J Vet Res; 2006 Jun; 67(6):1070-5. PubMed ID: 16740104 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in African grey parrots (Psittacus erithacus timneh). Flammer K; Nettifee Osborne JA; Webb DJ; Foster LE; Dillard SL; Davis JL Am J Vet Res; 2008 Jan; 69(1):114-21. PubMed ID: 18167096 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation. Brüggemann RJ; Antonius T; Heijst Av; Hoogerbrugge PM; Burger DM; Warris A Ther Drug Monit; 2008 Dec; 30(6):643-6. PubMed ID: 19057370 [TBL] [Abstract][Full Text] [Related]
9. To treat or not to treat with antifungal agents? Schoeni MH J Cyst Fibros; 2005 Dec; 4(4):213-4. PubMed ID: 16253572 [No Abstract] [Full Text] [Related]
10. Pharmacokinetics of voriconazole during continuous venovenous hemofiltration. Spriet I; Wauters J; Willems L Ther Drug Monit; 2011 Jun; 33(3):372; author reply 372. PubMed ID: 21566509 [No Abstract] [Full Text] [Related]
11. Oral voriconazole dose in children: one size does not fit all. Goutelle S; Larcher R; Padoin C; Mialou V; Bleyzac N Clin Infect Dis; 2010 Oct; 51(7):870; author reply 871. PubMed ID: 20809842 [No Abstract] [Full Text] [Related]
12. Therapeutic drug monitoring of voriconazole in children. Chen J; Chan C; Colantonio D; Seto W Ther Drug Monit; 2012 Feb; 34(1):77-84. PubMed ID: 22210097 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses. Colitz CM; Latimer FG; Cheng H; Chan KK; Reed SM; Pennick GJ Am J Vet Res; 2007 Oct; 68(10):1115-21. PubMed ID: 17916020 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses. Clode AB; Davis JL; Salmon J; Michau TM; Gilger BC Am J Vet Res; 2006 Feb; 67(2):296-301. PubMed ID: 16454636 [TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of voriconazole in falcons. Schmidt V; Demiraj F; Di Somma A; Bailey T; Ungemach FR; Krautwald-Junghanns ME Vet Rec; 2007 Aug; 161(8):265-8. PubMed ID: 17720963 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in Hispaniolan Amazon parrots (Amazona ventralis). Sanchez-Migallon Guzman D; Flammer K; Papich MG; Grooters AM; Shaw S; Applegate J; Tully TN Am J Vet Res; 2010 Apr; 71(4):460-7. PubMed ID: 20367055 [TBL] [Abstract][Full Text] [Related]
17. Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients. Mohammedi I; Piens MA; Padoin C; Robert D Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):358-60. PubMed ID: 15875225 [No Abstract] [Full Text] [Related]
18. Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections. Boyd NK; Zoellner CL; Swancutt MA; Bhavan KP Antimicrob Agents Chemother; 2012 Nov; 56(11):6001-2. PubMed ID: 22890768 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis. Seyedmousavi S; Mouton JW; Verweij PE; Brüggemann RJ Expert Rev Anti Infect Ther; 2013 Sep; 11(9):931-41. PubMed ID: 24053274 [TBL] [Abstract][Full Text] [Related]
20. Subtherapeutic itraconazole and voriconazole levels in children with cystic fibrosis. Bentley S; Gupta A; Balfour-Lynn IM J Cyst Fibros; 2013 Jul; 12(4):418-9. PubMed ID: 23103055 [No Abstract] [Full Text] [Related] [Next] [New Search]